Researchers have identified one of the proteins that may be responsible for causing food allergies, which could lead to the development of more accurate non-invasive tests to identify true food allergies, according to a study published in the July issue of Gastroenterology, the journal for the members of the American Gastroenterological Association.
Food allergies often present a unique problem for allergy testing since not every patient has detectable levels of immunoglobulin E (IgE) in their serum, especially patients with delayed allergies. A number of reliable testing methods exist for food and other allergies, including skin tests and serum IgE tests, however, they may not accurately diagnose food allergies. The oral food challenge is considered the most accurate test for food allergies but is expensive to administer and has to be done in a controlled environment. Immunoglobulin (antibody) E is a protein produced by plasma cells (or B-Cells , a type of lymphocyte ), which is designed to control the immune response in extracellular fluids by binding to substances in the body that are recognized as foreign.
The study, conducted at the Mount Sinai School of Medicine, New York, showed for the first time that CD23, a protein normally expressed in a person's intestinal tract, acts as a receptor for IgE, a protein associated with allergic reactions, and enables it to participate in food-allergic reactions.
"We believe that the presence of CD23 may provide a surrogate method of looking at the gut without invasive tests like biopsies," according to M. Cecilia Berin, PhD, assistant professor, pediatrics/allergy and immunology, Mount Sinai and lead author of the study.
Results of this study showed that CD23 was detectable in stool samples from food allergic patients, but not the controls, suggesting either increased levels of CD23 on intestinal cells or an allergen-induced shedding of CD23 in food allergic patients. Additionally, researchers found a strong correlation between the level of CD23 and food-specific IgE in the stool, demonstrated by the availability of IgE antibodies to interact with CD23 on the outside surface of the gastrointestinal wall.
Researchers collected stool samples from nine pediatric patients (age range three to 17 years) who underwent an oral food challenge, during which they were administered either egg or milk in a controlled environment. All patients had a history of allergies to these foods and had reacted positively through other testing methods. Their symptoms, which occurred less than two hours after the food challenge, included skin reactions, breathing problems and gastrointestinal problems or a combination. They were matched to five pediatric controls with no food allergies.
"Based on the results of our study, we intend to conduct larger scale trials of patients with food allergic disorder to determine how CD23 in the stool correlates with clinical findings," according to Dr. Berin. "We hope to determine that CD23 offers a promising target for food allergies that leads to more accurate, easier to tolerate tests for these patients."
Food allergies affect an estimated six to eight percent of American children age four years or younger and approximately two percent of adults, according to the National Institute of Allergy and Infectious Diseases (NIAID). The study authors estimate that three and a half to four percent of these food allergies are IgE-mediated. While many people believe they have food allergies, the majority of individuals experience food intolerance.
Food allergies are an exaggerated immune response in which the body produces histamines and antibodies that induce symptoms in the gastrointestinal tract, airways and skin, and in the most severe cases induces anaphylactic shock, an often fatal systemic reaction. These allergies are often characterized by abdominal pain, diarrhea, vomiting, hives, swelling of the eyelids, face, lips and tongue, shortness of breath or wheezing and difficulty swallowing, among other symptoms. The most common allergens are peanuts, tree nuts, shellfish, fish, wheat, milk, eggs and soy.
Aimee Frank | EurekAlert!
Scientists develop tiny tooth-mounted sensors that can track what you eat
22.03.2018 | Tufts University
NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
22.03.2018 | Trade Fair News
22.03.2018 | Earth Sciences
22.03.2018 | Earth Sciences